Sernova Corp. (OTCMKTS:SEOVF) Sees Significant Decline in Short Interest

Sernova Corp. (OTCMKTS:SEOVF) saw a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 1,900 shares, a drop of 98.2% from the March 31st total of 106,700 shares. Based on an average trading volume of 41,900 shares, the days-to-cover ratio is currently 0.0 days.

Sernova Trading Up 2.9 %

Shares of SEOVF stock traded up $0.01 on Friday, reaching $0.32. 14,800 shares of the stock were exchanged, compared to its average volume of 19,347. The company has a quick ratio of 1.20, a current ratio of 1.20 and a debt-to-equity ratio of 0.14. The stock has a market cap of $96.64 million, a P/E ratio of -3.54 and a beta of 1.16. The firm has a 50 day moving average of $0.40 and a two-hundred day moving average of $0.47. Sernova has a 1-year low of $0.29 and a 1-year high of $0.83.

Sernova (OTCMKTS:SEOVF) last announced its quarterly earnings results on Monday, March 18th. The company reported ($0.02) earnings per share for the quarter.

Analyst Ratings Changes

Separately, Raymond James assumed coverage on Sernova in a research note on Thursday, April 4th. They issued a “market perform” rating and a $1.50 target price on the stock.

About Sernova

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.